Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab Plus PRP for High Risk Proliferative Diabetic Retinopathy
NCT01102946Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in proliferative diabetic retinopathy (PDR), sponsored by Universidade de São Paulo. Started Feb 2009; status: completed.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT01102946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01102946.